Referenser

  1. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-55.

  2. Hutchings MI, Truman AW, Wilkinson B. Antibiotics: past, present and future. Curr Opin Microbiol. 2019;51:72-80.

  3. Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis. 2013;13(12):1057-98.

  4. Folkhälsomyndigheten. Swedres-Svarm 2022  [citerad 2023- 10-13]. Hämtad från: https://www.folkhalsomyndigheten.se/publikationer-och-material/publikationsarkiv/s/swedres-svarm-2022/

  5. Woerther PL, Andremont A, Kantele A. Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level. J Travel Med. 2017;24(suppl_1):S29-s34.

  6. European Centre for Disease Prevention and Control. Antimicrobial consumption dashboard (Esac-Net) [Internet]. Solna: ECDC;  [uppdaterad data 2021; citerad 2023- 09-12]. Hämtad från: https://www.ecdc.europa.eu/en/antimicrobial-consumption/surveillance-and-disease-data/database

  7. Dahlén E, Collin J, Hellman J, Norman C, Nauclér P, Ternhag A. The effect of absent or deferred antibiotic treatment on complications of common infections in primary care. Int J Infect Dis. 2022;124:181-6.

  8. Folkhälsomyndigheten. Nationell samverkansfunktion Solna [uppdaterad 2022-03-10; citerad 2023- 10-27]. Hämtad från: https://www.folkhalsomyndigheten.se/smittskydd-beredskap/antibiotika-och-antibiotikaresistens/nationell-samverkansfunktion/

  9. Skydda antibiotikan: Folkhälsomyndigheten;  [citerad 2023- 10-27]. Hämtad från: https://skyddaantibiotikan.se/